META Pharmaceuticals Inc.
PrivateLast Round
Series A
Extension
Dec 1, 2024
Total Funding Raised
$21.1M
Company Overview
META Pharmaceuticals Inc. is a biopharmaceutical company that develops first-in-class small molecule drugs targeting immunometabolism for the treatment of autoimmune and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
META Pharmaceuticals Inc. Comparables
Compare META Pharmaceuticals Inc. with similar companies based on industry and business-model similarity.
META Pharmaceuticals Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 1, 2024 | ||||
| Series A | Mar 1, 2022 | ||||
| Seed | Sep 1, 2021 |
META Pharmaceuticals Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tiantu Capital | Series A, Seed |
| IMO Ventures | Series A Extension, Series A, Seed |
META Pharmaceuticals Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access